Ross Moat - Net Worth and Insider Trading

Ross Moat Net Worth

The estimated net worth of Ross Moat is at least $262,490 dollars as of 2025-07-04. Ross Moat is the CHIEF COMMERCIAL OFFICER of Kiniksa Pharmaceuticals International PLC and owns about 9,415 shares of Kiniksa Pharmaceuticals International PLC (KNSA) stock worth over $262,490. Details can be seen in Ross Moat's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ross Moat has not made any transactions after 2025-06-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Ross Moat

To

Ross Moat Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ross Moat owns 1 companies in total, including Kiniksa Pharmaceuticals International PLC (KNSA) .

Click here to see the complete history of Ross Moat’s form 4 insider trades.

Insider Ownership Summary of Ross Moat

Ticker Company Transaction Date Type of Owner
KNSA Kiniksa Pharmaceuticals International PLC 2025-06-03 Group VP & Rilonacept GM

Ross Moat Latest Holdings Summary

Ross Moat currently owns a total of 1 stock. Ross Moat owns 9,415 shares of Kiniksa Pharmaceuticals International PLC (KNSA) as of June 3, 2025, with a value of $262,490.

Latest Holdings of Ross Moat

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KNSA Kiniksa Pharmaceuticals International PLC 2025-06-03 9,415 27.88 262,490

Holding Weightings of Ross Moat


Ross Moat Form 4 Trading Tracker

According to the SEC Form 4 filings, Ross Moat has made a total of 5 transactions in Kiniksa Pharmaceuticals International PLC (KNSA) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Kiniksa Pharmaceuticals International PLC is the sale of 27,594 shares on June 3, 2025, which brought Ross Moat around $800,778.

Insider Trading History of Ross Moat

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ross Moat Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Ross Moat Ownership Network

Ownership Network List of Ross Moat

No Data

Ownership Network Relation of Ross Moat

Insider Network Chart


Ross Moat Owned Company Details

What does Kiniksa Pharmaceuticals International PLC do?

Who are the key executives at Kiniksa Pharmaceuticals International PLC?

Ross Moat is the Group VP & Rilonacept GM of Kiniksa Pharmaceuticals International PLC. Other key executives at Kiniksa Pharmaceuticals International PLC include Chief Business Officer Eben Tessari , Interim CFO Mark Ragosa , and Chief Accounting Officer Michael R Megna .

Kiniksa Pharmaceuticals International PLC (KNSA) Insider Trades Summary

Over the past 18 months, Ross Moat made 5 insider transaction in Kiniksa Pharmaceuticals International PLC (KNSA) with a net sale of 211,750. Other recent insider transactions involving Kiniksa Pharmaceuticals International PLC (KNSA) include a net sale of 244,593 shares made by Eben Tessari , a net sale of 408,607 shares made by Sanj K Patel , and a net sale of 246,546 shares made by Mark Ragosa .

In summary, during the past 3 months, insiders sold 522,197 shares of Kiniksa Pharmaceuticals International PLC (KNSA) in total and bought 0 shares, with a net sale of 522,197 shares. During the past 18 months, 1,297,332 shares of Kiniksa Pharmaceuticals International PLC (KNSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,297,332 shares.

Kiniksa Pharmaceuticals International PLC (KNSA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kiniksa Pharmaceuticals International PLC Insider Transactions

No Available Data

Ross Moat Mailing Address

Above is the net worth, insider trading, and ownership report for Ross Moat. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Ross Moat's mailing address is: Hamilton D0 Hm11.